通气/灌注PET/CT与CT肺动脉造影诊断肺栓塞的独立与增量价值:PECAN初步研究
该初步研究前瞻性纳入24例疑似急性肺栓塞的癌症患者,在24小时内同时完成68Ga-V/Q PET/CT与CTPA检查。独立判读时18例(75%)诊断一致阴性;6例不一致者经融合共识判读后2例明确诊断,V/Q PET对4例(17%)患者管理产生影响。结论认为V/Q PET/CT可行且可能对CTPA不确定或孤立亚段血栓患者提供额外鉴别信息。
要点
- 24例癌症疑似急性PE患者中,18例(75%)独立判读一致阴性。
- 6例不一致者中,3例CTPA示单发亚段血栓而V/Q PET/CT阴性。
- V/Q PET/CT对4例(17%)患者治疗管理产生影响。
核心结论
- 本初步研究证明V/Q PET/CT用于疑似PE患者管理具有可行性和潜在效用。
- V/Q PET/CT可能对CTPA结果模棱两可或仅见孤立亚段血栓的患者特别有价值,可提供额外鉴别信息以帮助决定是否抗凝。
研究设计与样本
- 前瞻性初步研究,纳入24例疑似急性PE的癌症患者。
- 所有患者均在24小时内完成68Ga-V/Q PET/CT和CTPA检查。
- PET/CT在吸入Technegas发生器制备的Galligas并给予68Ga-大颗粒聚合白蛋白后采集。
- PET/CT与CTPA先独立盲法判读,随后由放射科与核医学科医师共识融合判读。
主要发现
- 独立判读时18例(75%)诊断结论一致为阴性。
- 6例独立判读不一致者中,融合判读V/Q PET/CTPA使2例达成共识结论(1例排除PE,1例确认PE),与V/Q PET/CT初始诊断结论相似。
- 剩余4例中,3例CTPA示单发亚段血栓而V/Q PET/CT阴性,其中2例未接受长期抗凝且3年随访期间无静脉血栓栓塞事件。
- 第3例(CTPA单发亚段血栓而V/Q PET/CT阴性)及1例V/Q PET/CT阳性但CTPA阴性的患者出现急性并发症,无法就V/Q PET/CT结果在PE管理中的适当性得出结论。
- 总体上,V/Q PET对4例(17%)患者的管理产生了影响。
临床怎么用
- 对癌症疑似急性PE患者,V/Q PET/CT可作为CTPA的补充或替代影像手段。
- CTPA结果模棱两可或仅见孤立亚段血栓时,V/Q PET/CT可提供额外鉴别信息以指导抗凝决策。
- V/Q PET/CT具有采集时间短和辐射剂量低的优势,且68Ga发生器可及性增加,有望替代V/Q SPECT/CT。
局限性
- 本研为初步研究,样本量仅24例。
- 部分患者出现急性并发症,妨碍了对V/Q PET/CT结果管理适当性的评估。
- 3年随访中2例未抗凝且无静脉血栓栓塞事件,但样本量小需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This pilot study assessed the independent and incremental value of 68Ga-V/Q PET/CT as compared with CT pulmonary angiography (CTPA) for the management of cancer patients with suspected acute pulmonary embolism (PE). METHODS: All 24 cancer patients with suspected acute PE prospectively recruited underwent both 68Ga-V/Q PET/CT and CTPA within 24 h. PET/CT was acquired after inhalation of Galligas prepared using a Technegas generator and administration of 68Ga-macroaggregated albumin. Initially, PET/CT and CTPA scans were read independently with the reader blinded to the results of the other imaging study. CTPA and PET/CT were then coregistered and reviewed by consensus between a radiologist and nuclear medicine physician. The therapeutic management was established by the managing physician based on all available data. RESULTS: The diagnostic conclusion was concordantly negative in 18 patients (75%). Of the six discordant diagnoses on independent reading, combined interpretation of V/Q PET/CTPA enabled a consensus conclusion in two patients, excluding PE in one and confirming PE in the other, similar to the initial diagnostic conclusion of the V/Q PET/CT. Of the remaining four patients, three had a single subsegmental thrombus on CTPA but a negative V/Q PET/CT scan, and two of these did not receive long-term anticoagulation and did not have a venous thromboembolic event during a 3-year follow-up period. The third patient, along with a patient with a positive V/Q PET/CT scan but a negative CTPA scan, presented with acute complications preventing any conclusions with regard to the appropriateness of the V/Q PET/CT results in the management of PE. Overall, V/Q PET had an impact on management in four patients (17%). CONCLUSION: In this pilot study, we demonstrated the feasibility and potential utility of V/Q PET/CT for the management of patients with suspected PE. V/Q PET/CT may be of particular relevance in patients with equivocal findings or isolated subsegmental findings on CTPA, adding further discriminatory information to allow important decision-making regarding the use or withholding of anticoagulation. Given the other advantages of V/Q PET/CT (reduced acquisition time, low radiation dose), and with the increasing availability of 68Ga generators, PET/CT is a potential replacement for V/Q SPECT/CT imaging.
引用
- Le Roux PY, Iravani A, Callahan J, et al. Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study. Eur J Nucl Med Mol Imaging. 2019. PMID: 31044265. doi:10.1007/s00259-019-04338-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。